BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20441926)

  • 1. The synthesis and characterization of cellular membrane affinity chromatography columns for the study of human multidrug resistant proteins MRP1, MRP2 and human breast cancer resistant protein BCRP using membranes obtained from Spodoptera frugiperda (Sf9) insect cells.
    Bhatia PA; Moaddel R; Wainer IW
    Talanta; 2010 Jun; 81(4-5):1477-81. PubMed ID: 20441926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a multiple endogenously expressed adenosine triphosphate-binding cassette transporters using nuclear and cellular membrane affinity chromatography columns.
    Habicht KL; Singh NS; Khadeer MA; Shimmo R; Wainer IW; Moaddel R
    J Chromatogr A; 2014 Apr; 1339():80-85. PubMed ID: 24642394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis and characterization of a nuclear membrane affinity chromatography column for the study of human breast cancer resistant protein (BCRP) using nuclear membranes obtained from the LN-229 cells.
    Habicht KL; Frazier C; Singh N; Shimmo R; Wainer IW; Moaddel R
    J Pharm Biomed Anal; 2013 Jan; 72():159-62. PubMed ID: 23146242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactions.
    Breedveld P; Zelcer N; Pluim D; Sönmezer O; Tibben MM; Beijnen JH; Schinkel AH; van Tellingen O; Borst P; Schellens JH
    Cancer Res; 2004 Aug; 64(16):5804-11. PubMed ID: 15313923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation and efflux of ATP-binding cassette transporter substrate 2,4-dinitrophenyl-S-glutathione from cultured human term placental villous tissue fragments.
    Vaidya SS; Walsh SW; Gerk PM
    Mol Pharm; 2009; 6(6):1689-702. PubMed ID: 19397308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of terpenoids on multidrug resistance-associated protein 2- and breast cancer resistance protein-mediated transport.
    Yoshida N; Takada T; Yamamura Y; Adachi I; Suzuki H; Kawakami J
    Drug Metab Dispos; 2008 Jul; 36(7):1206-11. PubMed ID: 18436619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP.
    Römermann K; Wanek T; Bankstahl M; Bankstahl JP; Fedrowitz M; Müller M; Löscher W; Kuntner C; Langer O
    Nucl Med Biol; 2013 Oct; 40(7):873-8. PubMed ID: 23845421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours.
    Bart J; Hollema H; Groen HJ; de Vries EG; Hendrikse NH; Sleijfer DT; Wegman TD; Vaalburg W; van der Graaf WT
    Eur J Cancer; 2004 Sep; 40(14):2064-70. PubMed ID: 15341980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectivity in the Efflux of Glucuronides by Human Transporters: MRP4 Is Highly Active toward 4-Methylumbelliferone and 1-Naphthol Glucuronides, while MRP3 Exhibits Stereoselective Propranolol Glucuronide Transport.
    Järvinen E; Troberg J; Kidron H; Finel M
    Mol Pharm; 2017 Oct; 14(10):3299-3311. PubMed ID: 28850245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells.
    Karlsson JE; Heddle C; Rozkov A; Rotticci-Mulder J; Tuvesson O; Hilgendorf C; Andersson TB
    Drug Metab Dispos; 2010 Apr; 38(4):705-14. PubMed ID: 20071452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
    Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
    J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective binding of chiral ligands to single nucleotide polymorphisms of the human organic cation transporter-1 determined using cellular membrane affinity chromatography.
    Moaddel R; Bighi F; Yamaguchi R; Patel S; Ravichandran S; Wainer IW
    Anal Biochem; 2010 Jun; 401(1):148-53. PubMed ID: 20206116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug-drug interaction to support regulatory submissions.
    Elsby R; Smith V; Fox L; Stresser D; Butters C; Sharma P; Surry DD
    Xenobiotica; 2011 Sep; 41(9):764-83. PubMed ID: 21612343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of SN38-resistant T47D breast cancer cell sublines overexpressing BCRP, MRP1, MRP2, MRP3, and MRP4.
    Lee HJ; Choi CH
    BMC Cancer; 2022 Apr; 22(1):446. PubMed ID: 35461219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone.
    Lagas JS; van der Kruijssen CM; van de Wetering K; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Jan; 37(1):129-36. PubMed ID: 18845662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.
    Bakos E; Evers R; Sinkó E; Váradi A; Borst P; Sarkadi B
    Mol Pharmacol; 2000 Apr; 57(4):760-8. PubMed ID: 10727523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
    Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
    Xiao L; Yi T; Chen M; Lam CW; Zhou H
    Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of hesperetin glucuronide conjugates with human BCRP, MRP2 and MRP3 as detected in membrane vesicles of overexpressing baculovirus-infected Sf9 cells.
    Brand W; Oosterhuis B; Krajcsi P; Barron D; Dionisi F; van Bladeren PJ; Rietjens IM; Williamson G
    Biopharm Drug Dispos; 2011 Dec; 32(9):530-5. PubMed ID: 22083890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin.
    Wortelboer HM; Usta M; van der Velde AE; Boersma MG; Spenkelink B; van Zanden JJ; Rietjens IM; van Bladeren PJ; Cnubben NH
    Chem Res Toxicol; 2003 Dec; 16(12):1642-51. PubMed ID: 14680379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.